Related Experiment Video
Updated: Jan 4, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.4K
Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer properties
Cristina P Matos1, Zelal Adiguzel2, Yasemin Yildizhan2
1Centro de Química Estrutural, Instituto Superior Técnico, Departamento de Engenharia Quimica, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal.
Data in Brief
|November 5, 2019
Summary
Iron(III) complexes with phenanthroline derivatives show promise as anticancer agents. These compounds were characterized, and their DNA interactions and efficacy against cancer cells were evaluated, revealing potential therapeutic applications.
Area of Science:
- Coordination Chemistry
- Bioinorganic Chemistry
- Medicinal Chemistry
Background:
- Iron complexes are explored for their potential as anticancer agents due to their unique electronic properties and biological relevance.
- Phenanthroline derivatives and related ligands are known to interact with DNA and exhibit cytotoxic effects, making them attractive scaffolds for drug development.
Purpose of the Study:
- To synthesize and characterize novel mixed-ligand iron(III) complexes incorporating a tripodal aminophenolate ligand and various phenanthroline-based co-ligands.
- To investigate the hydrolytic stability and DNA-binding interactions of these iron(III) complexes.
- To evaluate the anticancer efficacy and elucidate the cell death mechanisms induced by these complexes in human cancer cell lines.
Main Methods:
- Synthesis and characterization of iron(III) complexes using UV-Vis absorption spectroscopy and magnetic measurements.
- Assessment of hydrolytic stability in physiological buffers and DNA interaction studies using spectroscopic techniques.
- In vitro anticancer activity evaluation against HeLa, H1299, and MDA-MB-231 cancer cell lines, including analysis of cell death pathways.
Main Results:
- A series of novel mixed-ligand iron(III) complexes with diverse phenanthroline derivatives were successfully synthesized and characterized.
- The complexes exhibited varying degrees of hydrolytic stability and demonstrated interactions with calf thymus DNA.
- Several iron(III) complexes displayed significant anticancer efficacy, inducing cell death through distinct mechanisms in the tested cancer cell lines.
Conclusions:
- Iron(III) complexes containing phenanthroline derivatives represent a promising class of compounds for anticancer drug development.
- The observed DNA interactions and cytotoxic effects highlight the potential of these complexes as therapeutic agents.
- Further investigation into the structure-activity relationships and mechanisms of action could lead to the design of more potent anticancer drugs.
